Clarification of Optimal Anticoagulation Through Genetics

NCT00839657 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1015

Enrollment

NIH

Sponsor class

Conditions

Stroke
Venous Thrombosis
Atrial Fibrillation
Atrial Flutter

Interventions

BEHAVIORAL: Genotype-guided dosing algorithm for warfarin
BEHAVIORAL: Clinical-guided dosing algorithm for warfarin

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborators

[object Object]